Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.

Tu W, Chen PA, Koenig N, Gomez D, Fujiwara E, Gill MJ, Kong L, Power C.

J Neurovirol. 2019 Sep 13. doi: 10.1007/s13365-019-00791-6. [Epub ahead of print]

PMID:
31520320
2.

Cervical cancer risk in women living with HIV across four continents: A multicohort study.

Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, Taghavi K, Moore RD, Goedert JJ, Gill MJ, Silverberg MJ, D'Souza G, Patel P, Castilho JL, Ross J, Sohn A, Bani-Sadr F, Taylor N, Paparizos V, Bonnet F, Verbon A, Vehreschild JJ, Post FA, Sabin C, Mocroft A, Dronda F, Obel N, Grabar S, Spagnuolo V, Quiros-Roldan E, Mussini C, Miro JM, Meyer L, Hasse B, Konopnicki D, Roca B, Barger D, Clifford GM, Franceschi S, Egger M, Bohlius J.

Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32260. [Epub ahead of print]

PMID:
31215037
3.

The Impact of "Churn" on Plasma HIV Burden Within a Population Under Care.

Krentz HB, Vu Q, Gill MJ.

Open Forum Infect Dis. 2019 Apr 26;6(6):ofz203. doi: 10.1093/ofid/ofz203. eCollection 2019 Jun.

4.

Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.

Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Hessol NA, Achenbach CJ, Brooks JT, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Patel P, Rabkin CS, Rachlis A, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Clin Infect Dis. 2019 May 2. pii: ciz329. doi: 10.1093/cid/ciz329. [Epub ahead of print]

PMID:
31044245
5.

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical Care.

Rossi C, Young J, Martel-Laferrière V, Walmsley S, Cooper C, Wong A, Gill MJ, Klein MB; Canadian Co-Infection Cohort Investigators .

Open Forum Infect Dis. 2019 Feb 13;6(3):ofz055. doi: 10.1093/ofid/ofz055. eCollection 2019 Mar.

6.

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.

Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Achenbach CJ, Hessol NA, D'Souza G, Gebo KA, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Park LS, Rabkin CS, Salters K, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Lancet HIV. 2019 Apr;6(4):e240-e249. doi: 10.1016/S2352-3018(18)30360-6. Epub 2019 Feb 27.

PMID:
30826282
7.

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, Rabkin CS, Klein DB, Lo Re V, Sterling TR, Desir FA, Lichtenstein K, Willig J, Rachlis AR, Kirk GD, Anastos K, Palella FJ Jr, Thorne JE, Eron J, Jacobson LP, Napravnik S, Achenbach C, Mayor AM, Patel P, Buchacz K, Jing Y, Gange SJ; North American AIDS Cohort Collaboration on Research and Design.

Lancet HIV. 2019 Feb;6(2):e93-e104. doi: 10.1016/S2352-3018(18)30295-9. Epub 2019 Jan 22. Erratum in: Lancet HIV. 2019 Apr 2;:.

PMID:
30683625
8.

De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings.

Krentz HB, Campbell S, Lahl M, Gill MJ.

HIV Med. 2019 Mar;20(3):214-221. doi: 10.1111/hiv.12701. Epub 2019 Jan 11.

PMID:
30632660
9.

Impact of three decades of antiretroviral therapy in a longitudinal population cohort study.

Hanhoff N, Vu Q, Lang R, Gill MJ.

Antivir Ther. 2019;24(3):153-165. doi: 10.3851/IMP3287.

PMID:
30614788
10.

Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates.

Bradley H, Althoff KN, Buchacz K, Brooks JT, Gill MJ, Horberg MA, Kitahata MM, Marconi V, Mayer KH, Mayor A, Moore R, Mugavero M, Napravnik S, Paz-Bailey G, Prejean J, Rebeiro PF, Rentsch CT, Shouse RL, Silverberg MJ, Sullivan PS, Thorne JE, Yehia B, Rosenberg ES.

Ann Epidemiol. 2019 Mar;31:3-7. doi: 10.1016/j.annepidem.2018.11.005. Epub 2018 Nov 22.

PMID:
30529086
11.

Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Gomez D, Power C, Gill MJ, Koenig N, Vega R, Fujiwara E.

J Neurovirol. 2019 Feb;25(1):72-84. doi: 10.1007/s13365-018-0685-6. Epub 2018 Dec 5.

PMID:
30519968
12.

HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction.

Asahchop EL, Branton WG, Krishnan A, Chen PA, Yang D, Kong L, Zochodne DW, Brew BJ, Gill MJ, Power C.

JCI Insight. 2018 Dec 6;3(23). pii: 122450. doi: 10.1172/jci.insight.122450.

13.

Managing HIV infection in patients older than 50 years.

McMillan JM, Krentz H, Gill MJ, Hogan DB.

CMAJ. 2018 Oct 22;190(42):E1253-E1258. doi: 10.1503/cmaj.171409. Review. No abstract available.

PMID:
30348740
14.

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.

van Santen DK, van der Helm JJ, Touloumi G, Pantazis N, Muga R, Gunsenheimer-Bartmeyer B, Gill MJ, Sanders E, Kelleher A, Zangerle R, Porter K, Prins M, Geskus RB; CASCADE Collaboration within EuroCoord.

AIDS. 2019 Feb 1;33(2):327-337. doi: 10.1097/QAD.0000000000002040.

PMID:
30325767
15.

Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration.

Ingle SM, Crane HM, Glass TR, Yip B, Lima VD, Gill MJ, Hanhoff N, Ammassari A, Mugavero MJ, Tate JP, Guest J, Turner NL, May MT, Sterne JAC.

J Clin Med. 2018 Oct 5;7(10). pii: E328. doi: 10.3390/jcm7100328.

16.

Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.

Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):421-429. doi: 10.1097/QAI.0000000000001842.

PMID:
30211722
17.

A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada.

Lang R, Read R, Krentz HB, Peng M, Ramazani S, Vu Q, Gill MJ.

BMJ Open. 2018 Jul 10;8(7):e021544. doi: 10.1136/bmjopen-2018-021544.

18.

Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).

Giles ML, Achhra AC, Abraham AG, Haas AD, Gill MJ, Lee MP, Luque M, McGowan C, Cornell M, Braitstein P, de Rekeneire N, Becquet R, Wools-Kaloustian K, Law M.

J Int AIDS Soc. 2018 Jun;21(6):e25149. doi: 10.1002/jia2.25149.

19.

Combating the HIV reservoirs.

van Marle G, Church DL, van der Meer F, Gill MJ.

Biotechnol Genet Eng Rev. 2018 Apr;34(1):76-89. doi: 10.1080/02648725.2018.1471641. Epub 2018 May 21. Review.

PMID:
29781356
20.

Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.

Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):499-504. doi: 10.1097/QAI.0000000000001719.

21.

Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.

Lavoie S, Caswell D, Gill MJ, Kadkhoda K, Charlton CL, Levett PN, Hatchette T, Garceau R, Maregmen J, Mazzulli T, Needle R, Kadivar K, Kim J.

J Clin Virol. 2018 Jul;104:23-28. doi: 10.1016/j.jcv.2018.03.014. Epub 2018 Apr 12.

PMID:
29704735
22.

Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study.

Lang R, Read R, Krentz HB, Ramazani S, Peng M, Gratrix J, Gill MJ.

BMC Infect Dis. 2018 Mar 13;18(1):125. doi: 10.1186/s12879-018-3038-4.

23.

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.

Rossi C, Saeed S, Cox J, Vachon ML, Martel-Laferrière V, Walmsley SL, Cooper C, Gill MJ, Hull M, Moodie EEM, Klein MB; Canadian Co-Infection Cohort Investigators.

AIDS. 2018 Mar 27;32(6):751-759. doi: 10.1097/QAD.0000000000001750.

24.

Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savings.

Krentz HB, Campbell S, Gill VC, Gill MJ.

HIV Med. 2018 Apr;19(4):290-298. doi: 10.1111/hiv.12578. Epub 2018 Jan 25.

PMID:
29368401
25.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

26.

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion.

Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, Young J, Bucher HC, Babiker AG; CASCADE Collaboration in EuroCoord.

HIV Med. 2018 Mar;19(3):184-194. doi: 10.1111/hiv.12567. Epub 2017 Dec 1.

27.

Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Tymchuk S, Gomez D, Koenig N, Gill MJ, Fujiwara E, Power C.

Can J Psychiatry. 2018 May;63(5):329-336. doi: 10.1177/0706743717737029. Epub 2017 Dec 11.

28.

Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States.

Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, Boyd CM, Kitahata MM, Crane HM, Gebo KA, Gill MJ, Silverberg MJ, Palella FJ, Patel P, Samji H, Thorne J, Rabkin CS, Mayor A, Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Clin Infect Dis. 2018 Apr 3;66(8):1230-1238. doi: 10.1093/cid/cix998.

29.

Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?

Garvey MI, Bradley CW, Biggs MJ, Holden E, Gill MJ.

J Hosp Infect. 2018 Mar;98(3):238-240. doi: 10.1016/j.jhin.2017.10.023. Epub 2017 Nov 8. No abstract available.

PMID:
29126992
30.

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.

Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, Gill MJ, Haddad E, Guimond JV, Wainberg MA, Baker GB, Cohen EA, Power C.

Retrovirology. 2017 Oct 16;14(1):47. doi: 10.1186/s12977-017-0370-5.

31.

HIV misdiagnosis: A root cause analysis leading to improvements in HIV diagnosis and patient care.

Lang R, Charlton C, Beckthold B, Kadivar K, Lavoie S, Caswell D, Levett PN, Horsman GB, Kim J, Gill MJ.

J Clin Virol. 2017 Nov;96:84-88. doi: 10.1016/j.jcv.2017.10.005. Epub 2017 Oct 9.

PMID:
29031156
32.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.

Engels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Clin Infect Dis. 2017 Aug 15;65(4):636-643. doi: 10.1093/cid/cix392.

33.

Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.

McLaren PJ, Pulit SL, Gurdasani D, Bartha I, Shea PR, Pomilla C, Gupta N, Gkrania-Klotsas E, Young EH, Bannert N, Del Amo J, Gill MJ, Gilmour J, Kellam P, Kelleher AD, Sönnerborg A, Zangerle R, Post FA, Fisher M, Haas DW, Walker BD, Porter K, Goldstein DB, Sandhu MS, de Bakker PIW, Fellay J.

J Infect Dis. 2017 Nov 27;216(9):1063-1069. doi: 10.1093/infdis/jix470. Erratum in: J Infect Dis. 2018 Jun 5;218(1):171.

34.

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).

Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, Monforte AD, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola D, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Clin Infect Dis. 2017 Sep 15;65(6):959-966. doi: 10.1093/cid/cix466.

35.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.

36.

Healthcare contacts among patients lost to follow-up in HIV care: review of a large regional cohort utilizing electronic health records.

Connors WJ, Krentz HB, Gill MJ.

Int J STD AIDS. 2017 Nov;28(13):1275-1281. doi: 10.1177/0956462417699464. Epub 2017 Mar 17.

PMID:
28632480
37.

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.

38.

A Flow-Based Model of the HIV Care Continuum in the United States.

Gonsalves GS, Paltiel AD, Cleary PD, Gill MJ, Kitahata MM, Rebeiro PF, Silverberg MJ, Horberg M, Abraham AG, Althoff KN, Moore R, Bosch RJ, Tang T, Hall HI, Kaplan EH.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):548-553. doi: 10.1097/QAI.0000000000001429.

39.

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.

Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB; Canadian Co-infection Cohort Study (CTN 222).

PLoS One. 2017 May 3;12(5):e0176282. doi: 10.1371/journal.pone.0176282. eCollection 2017.

40.

Determinants of risk-taking in HIV-associated neurocognitive disorders.

Gomez D, Power C, Gill MJ, Fujiwara E.

Neuropsychology. 2017 Oct;31(7):798-810. doi: 10.1037/neu0000366. Epub 2017 Mar 30.

PMID:
28358552
41.

First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.

Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, Samji H, Napravnik S, Ahmed T, Thorne JE, Bosch RJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Clin Infect Dis. 2017 Feb 15;64(4):459-467. doi: 10.1093/cid/ciw804.

42.

He never willed to have the will he has: Historicist narratives, "civilized" blame, and the need to distinguish two notions of free will.

Gill MJ, Cerce SC.

J Pers Soc Psychol. 2017 Mar;112(3):361-382. doi: 10.1037/pspa0000073. Epub 2017 Jan 9.

PMID:
28068114
43.

Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.

Hoehn N, Gill MJ, Krentz HB.

AIDS Care. 2017 May;29(5):564-569. doi: 10.1080/09540121.2016.1234678. Epub 2016 Sep 18.

PMID:
27642701
44.

On shifting the blame to humanity: Historicist narratives regarding transgressors evoke compassion for the transgressor but disdain for humanity.

Gill MJ, Getty PD.

Br J Soc Psychol. 2016 Dec;55(4):773-791. doi: 10.1111/bjso.12159. Epub 2016 Sep 9.

PMID:
27611443
45.

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

J Infect Dis. 2016 Sep 15;214(6):862-72. doi: 10.1093/infdis/jiw085. Epub 2016 Apr 18.

46.

Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.

Kyei SK, Ogbomo H, Li S, Timm-McCann M, Xiang RF, Huston SM, Ganguly A, Colarusso P, Gill MJ, Mody CH.

MBio. 2016 Aug 23;7(4). pii: e00878-16. doi: 10.1128/mBio.00878-16.

47.

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy.

Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

PLoS One. 2016 Aug 15;11(8):e0160460. doi: 10.1371/journal.pone.0160460. eCollection 2016.

48.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. Epub 2016 Aug 9.

50.

Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.

Asahchop EL, Akinwumi SM, Branton WG, Fujiwara E, Gill MJ, Power C.

AIDS. 2016 Aug 24;30(13):2021-31. doi: 10.1097/QAD.0000000000001160.

PMID:
27191977

Supplemental Content

Support Center